STAGE II RECTAL CANCER AJCC V8
Clinical trials for STAGE II RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HIV patients with anal cancer: personalized therapy shows promise
Disease control OngoingThis study tests a treatment plan tailored to risk level for people with HIV and anal cancer. Low-risk patients receive standard chemotherapy and radiation, while high-risk patients also get the immunotherapy drug nivolumab to help prevent the cancer from returning. The goal is t…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 22:37 UTC
-
Immunotherapy plus radiation may eliminate rectal cancer before surgery
Disease control OngoingThis study tests whether giving two immunotherapy drugs (nivolumab and ipilimumab) along with a short course of radiation can completely eliminate advanced rectal cancer before surgery. About 31 adults with a specific genetic type (MSI-H/dMMR) of stage II or III rectal cancer wil…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New chemo cocktail may help rectal cancer patients skip surgery
Disease control OngoingThis study tests whether a three-drug chemotherapy combination (FOLFIRINOX) works better than the usual two-drug combinations (FOLFOX or CAPOX) after chemoradiation for patients with stage II-III rectal cancer. The goal is to achieve a clinical complete response, meaning no cance…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Fasting during radiation may ease treatment side effects
Symptom relief OngoingThis study compares time-restricted eating (intermittent fasting) with standard nutritional counseling in 49 adults with prostate, cervical, or rectal cancer receiving radiation or chemoradiation. The goal is to see if fasting reduces treatment side effects and improves how well …
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 16, 2026 12:55 UTC
-
Cancer treatment costs under the microscope: new study tracks financial toll
Knowledge-focused OngoingThis study follows 565 people with stage I-III colon or rectal cancer to understand how treatment affects their finances and quality of life. Participants complete surveys about costs and financial well-being over 12 months. The goal is to help doctors better support patients fac…
Matched conditions: STAGE II RECTAL CANCER AJCC V8
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC